Neoadjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: An interim analysis of a multi-center, phase 3, randomized, controlled clinical trial.
JOURNAL OF CLINICAL ONCOLOGY（2021）
关键词
neoadjuvant transarterial infusion chemotherapy,hepatocellular carcinoma patients,hepatocellular carcinoma,multi-center
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要